DeepMed Research

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Xeomin® and Gait Related Mobility After Stroke

Phase 4

Recruiting

Conditions: Stroke

Interventions: Drug: Xeomin®

First Posted Date: 2021-06-01

Last Posted Date: 2025-01-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT04908423

Locations: 🇺🇸
Carolinas Rehabilitation, Charlotte, North Carolina, United States

Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

Phase 3

Withdrawn

Conditions: Endometrial Hyperplasia

Interventions: Drug: Levonorgestrel Drug Implant
Drug: Megestrol Acetate

First Posted Date: 2021-05-21

Last Posted Date: 2023-07-05

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04897217

Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Other: Pathway Platform mobile app

First Posted Date: 2021-05-18

Last Posted Date: 2025-03-24

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 89

Registration Number: NCT04891224

Locations: 🇺🇸
Advocate Christ Medical Center, Oak Lawn, Illinois, United States

Intervention to Reduce Sugar-Sweetened Beverage (SSB) Consumption in Children and Families

Not Applicable

Completed

Conditions: Obesity, Childhood

Interventions: Behavioral: Pilot Intervention to reduce SSB consumption in children and families

First Posted Date: 2021-05-14

Last Posted Date: 2022-03-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 120

Registration Number: NCT04886817

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Menthol and Mint Experimental Tobacco Marketplace (ETM) Study

Not Applicable

Completed

Conditions: Cigarette Smoking
Vaping

Interventions: Behavioral: All e-liquid flavors
Behavioral: Mint, Menthol and Tobacco e-liquids
Behavioral: Menthol and Tobacco e-liquids
Behavioral: Tobacco e-liquids

First Posted Date: 2021-05-10

Last Posted Date: 2024-06-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 66

Registration Number: NCT04879225

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Repurposing Low-Dose Clonidine for PTSD in Veterans

Phase 3

Recruiting

Conditions: Sleep
Posttraumatic Stress Disorder
PTSD

Interventions: Drug: Clonidine Pill
Other: Placebo

First Posted Date: 2021-05-07

Last Posted Date: 2025-04-08

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 32

Registration Number: NCT04877093

Locations: 🇺🇸
Aurora Psychiatric Hospital, Wauwatosa, Wisconsin, United States

Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes

Not Applicable

Completed

Conditions: Gestational Weight Gain
Postpartum Weight Retention
Diabetes, Gestational

Interventions: Behavioral: Medically Tailored Meals

First Posted Date: 2021-04-30

Last Posted Date: 2025-04-29

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 12

Registration Number: NCT04866823

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Phase 2

Recruiting

Conditions: Head Neck Cancer
Oropharynx Squamous Cell Carcinoma
Oral Cavity Squamous Cell Carcinoma
Hypopharynx Squamous Cell Carcinoma
Larynx Squamous Cell Carcinoma
Metastatic Squamous Cell Carcinoma

Interventions: Drug: Pembrolizumab
Drug: Carboplatin
Drug: Paclitaxel

First Posted Date: 2021-04-26

Last Posted Date: 2025-04-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 35

Registration Number: NCT04858269

Locations: 🇺🇸
Wake Forest Baptist Health Sciences, Winston-Salem, North Carolina, United States

Non-Responsive Diabetic Macular Edema and Spironolactone

Phase 4

Withdrawn

Conditions: Diabetic Maculopathy

Interventions: Drug: Spironolactone 50 mg

First Posted Date: 2021-04-21

Last Posted Date: 2022-08-02

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04853355

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Testing the Feasibility of a Simplified Workflow for Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Procedure: CT Simulation

First Posted Date: 2021-04-14

Last Posted Date: 2022-07-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 36

Registration Number: NCT04844736

Locations: 🇺🇸
Iredell Memorial Hospital, Statesville, North Carolina, United States
🇺🇸
High Point Medical Center, High Point, North Carolina, United States
🇺🇸
Wake Forest Baptist Health - Lexington, Lexington, North Carolina, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy